| Literature DB >> 35507200 |
Noura O Abdelsamad1,2, Mona A Esawy3, Zeinab E Mahmoud1, Asmaa I El-Shazly4, Tarek R Elsayed5, Amira A Gamal4.
Abstract
Continue to hypothesize that honey is a storehouse of beneficial bacteria, and the majority of these isolates are levansucrase producers. Accordingly, ten bacterial strains were isolated from different honey sources. Four honey isolates that had the highest levansucrase production and levan yield were identified by the partial sequencing of the 16S rRNA gene as Achromobacter sp. (10A), Bacillus paralicheniformis (2M), Bacillus subtilis (9A), and Bacillus paranthracis (13M). The cytotoxicity of the selected isolates showed negative blood hemolysis. Also, they are sensitive to the tested antibiotics (Amoxicillin + Flucloxacillin, Ampicillin, Gentamicin, Benzathine benzylpenicillin, Epicephin, Vancomycin, Amikacin, and Zinol). The isolates had strong alkaline stability (pHs 9, 11) and were resistant to severe acidic conditions (29-100 percent). The tested isolates recorded complete tolerance to both H2O2 and the bile salt (0.3% Oxgall powder) after 24 h incubation. The cell-free supernatant of the examined strains had antifungal activities against C. Albicans with varying degrees. Also, isolates 2M and 13M showed strong activities against S. aureus. The isolates showed strong adhesion and auto-aggregation capacity. Isolate 10A showed the highest antioxidant activity (91.45%) followed by 2M (47.37%). The isolates recorded different catalase and protease activity. All isolates produced cholesterol oxidase and lipase with different levels. Besides, the four isolates reduced LDL (low-density lipoprotein) to different significant values. The cholesterol-reducing ability varied not only for strains but also for the time of incubation. The previous results recommended these isolates be used safely in solving the LDL problem.Entities:
Keywords: Antimicrobial; Cholesterol oxidase; Honey isolates; Levan; Levansucrase; Probiotic activity
Mesh:
Substances:
Year: 2022 PMID: 35507200 PMCID: PMC9068672 DOI: 10.1007/s11274-022-03259-8
Source DB: PubMed Journal: World J Microbiol Biotechnol ISSN: 0959-3993 Impact factor: 4.253
Survey on 10 bacterial cultures to produce levansucrase using shaken culture technique at 37 °C
| Bacterial isolates | Levansucrase activity (U/mL) | Protein (U/mg protein) | Specific activity | Final |
|---|---|---|---|---|
| 2M | 18.30 ± 0.15 | 0.38 | 48.15 | 6.21 |
| 9M | 0.015 ± 0.09 | 0.11 | 0.13 | 7.80 |
| 8M | 0.15 ± 0.12 | 1.25 | 0.12 | 4.24 |
| 1M | 0.03 ± 0.04 | 0.29 | 0.10 | 7.19 |
| 13M | 6.00 ± 0.06 | 1.1 | 5.45 | 7.26 |
| 9A | 20.30 ± 0.17 | 0.72 | 28.20 | 7.40 |
| 5A | 18.67 ± 0.05 | 0.80 | 23.34 | 6.70 |
| 13A | 6.24 ± 0.11 | 1.14 | 5.47 | 4.70 |
| 8A | 19.59 ± 0.18 | 0.81 | 24.19 | 7.40 |
| 10A | 31.85 ± 0.20 | 1.18 | 27.00 | 6.98 |
Fig. 1Neighbor-joining phylogenetic tree based on 16S rRNA gene sequences of four levansucrase-producing bacterial isolates obtained from different honey samples. Dark circles represent isolates obtained in this study
Fig. 2TLC for identification of polymer yielded by the levansucrase producing isolates after acid hydrolysis of the precipitate by HCl
Fig. 3Effect of different antibiotics on isolates surviving
Catalase and protease activity for the honey isolates
| Isolates NO | 9A | 10A | 13 M | 2 M |
|---|---|---|---|---|
| Enzymes | ||||
| Catalase | + 3 | + 3 | + | + |
| Protease | + 2 | + 2 | + | + 3 |
+ = weak
+ 2 = moderate
+ 3 = strong
Isolates tolerance to acidic pH (pHs 2 and 3.5) and alkaline pH (pHs 9 and 11) for 3 and 6 h and the bile salt for 24 h
| Bacterial isolates | Survival (%) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| pH 11 | pH 9 | pH 3 | pH 2 | Bile salt | |||||||||
| 1 h | 3 h | 6 h | 1 h | 3 h | 6 h | 1 h | 3 h | 6 h | 1 h | 3 h | 6 h | 24 h | |
| Control | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| 2M | 100 | 100 | 99.57 | 100 | 99.00 | 94.53 | 87.39 | 58.26 | 57.00 | 59.13 | 58.26 | 57.39 | 100 |
| 13M | 100 | 98.36 | 91.00 | 94.26 | 93.44 | 90.57 | 75.13 | 74.05 | 73.51 | 78.00 | 73.51 | 72.43 | 100 |
| 9A | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 88 | 98.09 | 96.56 | 58.01 | 100 |
| 10A | 100 | 100 | 100 | 100 | 100 | 100 | 37.30 | 31.11 | 29.00 | 38.54 | 37.00 | 32.00 | 100 |
Antimicrobial activities of the four probiotic isolates
| Bacterial | A. | ||||
|---|---|---|---|---|---|
| Antimicrobial activity (cm) | |||||
| 9A | 2.60 ± 0.02 | 3.00 ± 0.05 | No inhibition | No inhibition | 3.30 ± 0.11 |
| 10A | 2.80 ± 0.04 | 2.80 ± 0.07 | 3.10 ± 0.08 | No inhibition | No inhibition |
| 2M | 3.50 ± 0.15 | 2.00 ± 0.09 | 3.00 ± 0.09 | 4.10 ± 0.13 | No inhibition |
| 13M | 3.30 ± 0.25 | 3.50 ± 0.12 | No inhibition | 4.00 ± 0.18 | 5.00 ± 0.07 |
Fig. 4Evaluation of the isolates hydrophobicity and auto aggregation capacity
Fig. 5Tolerance of the isolates in medium supplemented with 0.1% H2O2 for 24 h
Fig. 6DPPH free radical scavenging activity for the cell-free supernatants of the four isolates
Fig. 7Determination of the total cholesterol (mg/dL) (a), The isolates influence LDL and HDL amounts after 24 h (b)
Evaluation the isolates’ ability to produce cholesterol oxidase and lipase
| Bacterial isolates | Cholesterol oxidase (µg/mL) | Lipase (U/mL) | ||
|---|---|---|---|---|
| 24 h | 48 h | 24 h | 48 h | |
| 9A | 19.75 ± 0.02 | 115.39 ± 0.05 | 1.2 ± 0.07 | 84 ± 0.08 |
| 10A | 41.53 ± 0.12 | 132.46 ± 0.11 | 1.2 ± 0.09 | 20.4 ± 0.06 |
| 13M | 15.99 ± 0.15 | 158.80 ± 0.19 | 1.8 ± 0.15 | 9.0 ± 0.09 |
| 2M | 0.0 | 105.31 ± 0.25 | 2.4 ± 0.14 | 10.2 ± 0.10 |